Dr. Zarir F. Udwadia, a consultant chest physician at Hinduja Hospital in Mumbai. News reports of at least a dozen cases of “totally drug resistant” tuberculosis (TB) in India recently have raised various questions, including why India and why now? In a letter to the editor in December’s issue of the journal Clinical Infectious Diseases […]
The U.S. Department of Health and Human Services (HHS) joined with the Kaiser Family Foundation (KFF) last week to discuss the department’s first ever global health strategy, outlined in a new report. HHS Secretary Kathleen Sebelius discussed the department’s burgeoning commitment to asserting its role in improving the health and well-being of people around the […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]